Mechanisms of resistance to CDK4/6 inhibitors in triple negative breast cancer

pSTAT3 in luminal breast cancer - results from BIG-2-98 trial

Increased long-term risk of breast cancer with high intra-tumour ER hetrogeneity

GTX-024 for androgen receptor positive breast cancer

Adaptive trial design on breast cancer

Identifying cancer in dense breast tissue

The molecular characterisation of oesophageal adenocarcinoma

Centrosomes in ovarian cancer

Hallmarks of cancer cell development

Pembrolizumab and indoximod for melanoma

Projections of cancer incidence and burden among the HIV-positive population in the United States through 2030

Nivolumab for NSCLC: five years on